viral spread within the central nervous system (CNS) and protects against mortality. The protective roles of specific ISGs against the mouse hepatitis virus (MHV) members of the coronaviruses are largely unknown. This study demonstrates a protective role of the ISG Ifit2 in encephalitis induced by the dual hepato-and neurotropic MHV-A59. Contrasting the mild encephalitis and 100% survival of MHV-A59-infected wild-type (wt) mice, nearly 60% of infected Ifit2 ؊/؊ mice exhibited severe encephalitis and succumbed between 6 and 8 days postinfection. Increased clinical disease in Ifit2 ؊/؊ mice coincided with higher viral loads and enhanced viral spread throughout the CNS parenchyma. Ifit2 ؊/؊ mice also expressed significantly reduced IFN-␣/␤ and downstream ISG mRNAs Ifit1, Isg15, and Pkr, while expression of proinflammatory cytokines and chemokines was only modestly affected in the CNS. Impaired IFN-␣/␤ induction in the absence of Ifit2 was confirmed by ex vivo mRNA analysis of microglia and macrophages, the prominent cell types producing IFN-␣/␤ following MHV CNS infection. Furthermore, both IFN-␣/␤ mRNA and protein production were significantly reduced in MHV-infected Ifit2 ؊/؊ relative to wt bone marrow-derived macrophages. Collectively, the data implicate Ifit2 as a positive regulator of IFN-␣/␤ expression, rather than direct antiviral mediator, during MHV-induced encephalitis.
T ype I interferons (IFN-␣/␤) provide a first line of defense against viral infections by limiting dissemination prior to the emergence of adaptive immune responses. Viral infection is sensed by endosomal Toll-like receptors (TLRs) or cytosolic retinoic acid-inducible gene I (RIG-I)-like receptors, which signal to activate NF-B, IFN-regulatory factor 3 (IRF3), IRF7, and downstream transcription of cytokine and IFN-␣/␤ genes (1, 2) . IFN-␣/␤ binding to its receptor induces JAK/STAT signaling and upregulation of hundreds of IFN-stimulated genes (ISGs) in infected and uninfected cells. The antiviral effector functions triggered by IFN-␣/␤ during a virus infection involve the concerted action of ISGs. In addition to direct innate antiviral factors, ISGs comprise cytokines, chemokines, and molecules associated with antigen presentation (major histocompatibility complex class I), thereby shaping adaptive immune responses (3) . The classically studied ISGs, RNase L, PKR, and Mx1, disrupt viral replication and subsequent spread by interfering with both viral and host cell transcription and translation (3, 4) . However, the susceptibility to innate antiviral effector mechanisms differs between viruses and may also be distinct between target organs as well as cell types and their differentiation state (4) (5) (6) . While the role of individual ISGs in reducing viral replication has been characterized for many viruses in vitro, their contribution to protection in individual cell types and tissues in vivo is not well defined.
The IFN-induced proteins with tetratricopeptide repeats (IFIT) are expressed at very low basal levels but are the most strongly induced ISGs during many viral infections (7) (8) (9) (10) . There are three Ifit family members in mice, Ifit1 (Isg56), Ifit2 (Isg54), and Ifit3 (Isg49), and four in humans, IFIT1, IFIT2, IFIT3 (Isg60), and IFIT5 (Isg58). Most IFIT functions and antiviral mechanisms were characterized based on in vitro analysis of human proteins. Both mouse and human IFIT1 and IFIT2 inhibit protein synthesis by binding to specific translation initiation factor subunits (10) (11) (12) . Human IFIT1, in heterocomplexes with other IFITs and cellular proteins, also binds and sequesters single-stranded 5= ppp-RNAs of vesicular stomatitis virus (VSV), thereby inhibiting viral replication (13) . Furthermore, analysis of 2=-O-methylation-deficient mutants of corona-, flavi-, and poxviruses demonstrated that IFIT proteins bind to RNAs having specific structures at the 5= ends (14, 15) . However, human IFIT2 can also bind doublestranded RNA without 5= ppp ends (16) . Human IFIT proteins also interact with downstream signaling molecules of the RIG-I/ MDA5 pathway (17, 18) . Depending on the stimulus and IFIT member, this interaction can suppress, enhance, or have no effect on IFN-␣/␤ induction (17, 18) . Amplification of IFN-␣/␤ expression by murine Ifit2 has also just recently been demonstrated in a model of lipopolysaccharide (LPS)-mediated sepsis (19) .
The variety of functions perturbed by IFITs in vitro (7) suggests numerous potential mechanisms of protection in vivo. VSV infection demonstrated that Ifit2, but not Ifit1, displays antiviral activ-ity by preventing VSV spread from the olfactory bulb into the central nervous system (CNS) parenchyma following intranasal infection (20) . However, Ifit2 deficiency did not alter viral replication or pathogenesis following direct intracranial VSV infection. This apparently Ifit2-independent VSV spread is likely due to the rapid neuronal replication rate, preventing effective IFN-␣/␤ and ISG induction prior to neuronal death (20) . As in VSV infection, Ifit2 also restricts West Nile virus (WNV) infection in specific regions of the brain (21) . Furthermore, there is no defect in IFN-␣/␤ production in the CNS following VSV infection of either Ifit1 Ϫ/Ϫ or Ifit2 Ϫ/Ϫ mice or WNV infection of Ifit2 Ϫ/Ϫ mice (20, 21) .
Similar to what is observed in other viral CNS infections (22) (23) (24) (25) , IFN-␣/␤-mediated innate immune responses are indispensable for controlling neurotropic coronavirus infection (26, 27) . Peripheral infection of IFN-␣/␤ receptor-deficient (Ifnar Ϫ/Ϫ ) mice with the dual liver-and CNS-tropic mouse hepatitis virus (MHV) strain A59 (MHV-A59) results in uncontrolled systemic spread, including to the CNS, and rapid mortality within 2 days (26) . Similarly, intracranial infection of Ifnar Ϫ/Ϫ mice with the sublethal, glia-tropic MHV variant JHM (MHV-JHM) results in glial dissemination, expanded tropism to neurons, and mortality within 7 to 8 days (27) . Relevant ISGs responsible for IFN-␣/␤mediated antiviral activity or neuroprotection during neurotropic coronavirus infections are starting to be studied (6, 14, (28) (29) (30) . The 2=-5=-oligoadenylate synthetase (OAS)/RNase L pathway, one of the best-characterized innate antiviral mechanisms (31), does not play a significant antiviral role during MHV infection due to rapid degradation of the RNase L-activating oligoadenylates synthesized by activated OAS (30) . RNase L deficiency therefore does not affect control of MHV-A59 in the CNS or liver early during infection (6, 30) . Similarly, RNase L only modestly prevents spread of the glia-tropic MHV-JHM to CNS microglia/macrophages; nevertheless, it provides protection from fatal disease (28) .
The present study assessed the role of Ifit2 as a potential factor contributing to innate antiviral activity during neurotropic coronavirus infection. The results demonstrate that Ifit2 protects against MHV-A59 encephalitis and death by promoting induction of IFN-␣/␤ and ISG expression, thereby stemming virus replication and spread within the CNS. The novel role of Ifit2 as a positive regulator of the IFN-␣/␤ pathway during MHV-A59 infection was directly attributed to microglia/macrophages in vivo and in vitro.
MATERIALS AND METHODS
Mice, viruses, and infections. C57BL/6 mice were obtained from the National Cancer Institute (Frederick, MD). Homozygous Ifit2 Ϫ/Ϫ mice on the C57BL/6 background were previously described (20) . All mice were housed under pathogen-free conditions at an accredited facility at the Cleveland Clinic Lerner Research Institute and used at 6 to 7 weeks of age. The dually liver-tropic and neurotropic MHV-A59 expressing enhanced green fluorescent protein (EGFP) and the parental wt MHV-A59 were both kindly provided by Volker Thiel, Kantonal Hospital, St. Gallen, Switzerland (32) . MHV-A59 expressing EGFP was used throughout, as preliminary experiments confirmed identical in vivo and in vitro pathogenicity. MHV-A59 was propagated and plaque assayed on delayed brain tumor (DBT) astrocytoma cell monolayers. Mice were infected intracranially in the left hemisphere with 1,000 PFU of MHV-A59 diluted in endotoxin-free Dulbecco's phosphate-buffered saline (PBS) in a final volume of 30 l. Clinical disease severity was graded daily using the following scale: 0, no disease symptoms; 1, ruffled fur; 2, hunched back/inability to turn upright; 3, severe hunching/wasting/hind limb paralysis; 4, moribund condition or death (33, 34) . Intraperitoneal infections were carried out with 1,000 PFU MHV-A59 in 300 l Dulbecco's PBS. This study was carried out in strict accordance with all provisions of the Animal Welfare Act, the Guide for the Care and Use of Laboratory Animals, and the PHS Policy on Humane Care and Use of Laboratory Animals. All animal experiments were performed in compliance with protocols approved by the Cleveland Clinic Institutional Animal Care and Use Committee (PHS assurance number A3047-01).
Virus titers in the CNS were determined as described previously (27, 28) . Briefly, brains and spinal cords were homogenized individually in Dulbecco's PBS using Tenbroeck tissue homogenizers. Homogenates were clarified by centrifugation at 400 ϫ g for 7 min at 4°C, and supernatants were stored at Ϫ70°C until assayed by plaque assay on DBT astrocytoma cell monolayers as described previously (35) .
RNA extraction, reverse transcription, and gene expression analysis. RNA was extracted using TRIzol reagent (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions and subjected to real-time PCR analysis as described previously (34) . In brief, snapfrozen tissues were dissociated with TRIzol in a Tissuelyser II (Qiagen, Valencia, CA), treated with chloroform, and RNA was precipitated with isopropyl alcohol, washed with 75% ethanol, and resuspended in RNase-free water (Gibco/Invitrogen, Grand Island, NY). Following treatment with DNase I using a DNA Free kit (Ambion, Austin, TX) for 30 min at 37°C following the manufacturer's instructions, 2 g RNA was converted to cDNA using the Moloney murine leukemia virus reverse transcriptase (Invitrogen) in buffer containing 10 mM deoxynucleoside triphosphate mix, 250 ng random hexamer primers and oligo(dT) (1:1 ratio) (Invitrogen). cDNA samples were diluted 10-fold in RNase-free water before analysis by quantitative real-time PCR using either SYBR green master mix (Applied Biosystems, Foster City, CA) or TaqMan technology as described previously (36) . The primer sequences for SYBR green PCR analysis are as follows: (F, forward; R, reverse): Gapdh, F, 5=-CATGGCCTTCCGTGTTCCTA-3=, and R, 5=-ATGCCTGCTTCACCACCTTCT-3=; Il-6, F, 5=-ACACATG TTCTCTGGGAAATCGT-3=, and R, 5=-AAGTGCATCATCGTTGTT CATACA-3=; Nos2, F, 5=-CCTGGTACGGGCATTGCT-3=, and R, 5=-CATGCGGCCTCCTTTGAG-3=; Tnf, F, 5=-GCCACCACGCTCTTCT GTCT-3=, and R, 5=-GGTCTGGGCCATAGAACTGATG-3=; Ccl5, F, 5=-GCAAGTGCTCCAATCTTGCA-3=, and 5=-CTTCTCTGGGTTGG CACACA-3=; Cxcl9, F, 5=-TGCACGATGCTCCTGCA-3=, and R, 5=-A GGTCTTTGAGGGATTTGTAGTGG-3=; Cxcl10, F, 5=-GACGGTCCG CTGCAACTG-3=, and R, 5=-GCTTCCCTATGGCCCTCATT-3=; and viral Nucleocapsid, F, 5=-GCCAAATAATCGCGCTAGAA-3=, and R, 5=-CCGAGCTTAGCCAAAACAAG-3=. All samples were run in duplicate on a 96-well plate using a 7500 fast real-time PCR system (Applied Biosystems) with an automatically set baseline and a manually set critical threshold (CT) at which the fluorescent signal becomes higher than the signals for all of the PCR pairs. Dissociation curves were used to confirm amplification of a single product for each primer pair per sample. Expression levels of Ccl2, Gapdh, Ifn␣4, Ifn␣5, Ifn␤1, Ifn␥, Ifit1, Ifit2, Isg15, Il-1␤ and Pkr were determined using TaqMan primer and probe sets, and 2ϫ universal TaqMan fast master mix (Applied Biosystems). Data were calculated relative to the housekeeping gene Gapdh using the following formula: 2 [CT(GAPDH) Ϫ CT(target gene)] ϫ 1,000 (36) .
Flow cytometry and fluorescence-activated cell sorting (FACS). Mice were perfused with PBS, and brains were homogenized in 4 ml of Dulbecco's PBS (pH 7.4) using Tenbroeck tissue homogenizers. Following centrifugation at 600 ϫ g for 10 min, cell pellets were resuspended in RPMI containing 25 mM HEPES (pH 7.2), adjusted to 30% Percoll (Pharmacia, Uppsala, Sweden) and underlaid with 1 ml of 70% Percoll. Following centrifugation at 800 ϫ g for 30 min at 4°C, cells were recovered from the 30%-70% interface, washed with RPMI, and suspended in FACS buffer (0.5% bovine serum albumin in Dulbecco's PBS). Fc␥ receptors were blocked with 1% polyclonal mouse serum and 1% rat anti-mouse CD16/ CD32 (clone 2.4G2; BD Biosciences, San Jose, CA) monoclonal antibody (MAb) for 20 min. Specific cell types were identified by staining with fluorescein isothiocyanate (FITC)-, phycoerythrin (PE)-, peridinin chlorophyll protein (PerCP)-, or allophycocyanin (APC)-conjugated MAb for 30 min on ice in FACS buffer. Expression of surface markers was characterized with MAb (all from BD Biosciences except where otherwise indicated) specific for CD45 (clone Ly-5), CD4 (clone GK1.5), CD8 (clone 53-6.7), CD11b (clone M1/70), F480 (Serotec, Raleigh, NC), Ly-6G (clone 1A8), and NK1.1 (clone PK136). Samples were analyzed using a FACSCalibur flow cytometer (BD Biosciences) and FlowJo 7 software (Treestar, Inc., Ashland, OR).
CNS-resident microglia, oligodendroglia, and infiltrating monocytes/ macrophages were isolated from brains of infected mice as described previously (36) . Briefly, brains from 7 or 8 mice were finely minced and triturated with 0.25% trypsin for 30 min at 37°C. Trypsin was quenched with RPMI containing 20% newborn calf serum; cells were washed in RPMI containing 25 mM HEPES and isolated from the 30%-70% Percoll interface as described above. Following blocking, cells were stained with APC-conjugated anti-CD45 (30-F11), and PE-conjugated anti-F4/80 MAb (Serotec) as described above. CNS-infiltrating CD45 hi F4/80 ϩ macrophages and resident CD45 lo F4/80 ϩ microglia were purified on a BD FACSAria cell sorter (BD Biosciences). Oligodendroglia were purified based on their CD45 Ϫ O4 ϩ phenotype following consecutive staining with unconjugated O4 MAb and anti-mouse IgM (FITC) MAb (R6-60.2) (BD Biosciences) as described previously (37, 38) . FACS-purified cells were resuspended in TRIzol and stored at Ϫ70°C.
Immunohistochemistry and immunofluorescence. Brains from PBS-perfused mice were divided along the midsagittal plane, and one half was fixed with 10% formalin and embedded in paraffin for viral antigen analysis. Viral nucleocapsid protein was identified by immunoperoxidase staining using MAb J3.3 as the primary antibody (39), biotinylated horse anti-mouse IgG as the secondary antibody, and streptavidin-conjugated horseradish peroxidase and 3,3=-diaminobenzidine substrate (Vectastain-ABC kit; Vector Laboratory, Burlingame, CA). High-resolution whole-slide scanning was performed using the Aperio ScanScope digital slide scanner (Carlsbad, CA) with the 40ϫ objective. Sections in each experimental group were evaluated in a blinded fashion, and representative fields were identified.
One half of the brains were embedded in TissueTek O.C.T. compound, flash frozen in liquid nitrogen, and stored at Ϫ70°C. Blocks were cut into 10 m sections in a cryostat at Ϫ20°C. Sections were fixed with 4% paraformaldehyde for 20 min at room temperature and permeabilized in 1% Triton-X in PBS for 30 min, and nonspecific antibody binding was blocked using 1% bovine serum albumin and 5% normal goat serum. Cells expressing Ifit2 were identified with rabbit-anti-Ifit2 antibody (20) , mouse anti-glial fibrillary acidic protein antibody (GFAP, G-A-5; Sigma-Aldrich, St. Louis, MO), Alexa-fluor 488 conjugated mouse anti-NeuN antibody (MAB377X; Chemicon), and rat anti-CD11b (M1/70; BD Biosciences) in combination with goat anti-rabbit Alexa-fluor 488/594-or goat anti-mouse Alexa-fluor 488/594-conjugated IgG (Invitrogen) as secondary antibodies. Similarly, virus-infected cells were identified using MAb J3.3 (39) and costained for cell type-specific markers with rabbit anti-Iba1 (019-19741; Wako, Richmond, VA), rabbit anti-glial fibrillary acidic protein (Z0334; Dako, Carpinteria, CA), or rabbit anti-NeuN (ABN78; Millipore, Temecula, CA) in combination with the secondary antibodies as described above. Sections were mounted with ProLong Gold antifade mounting medium containing 4=,6-diamidino-2-phenylindole (Invitrogen). Imaging of immunofluorescent sections was performed with a Leica DM4000B fluorescence microscope.
Bone marrow-derived macrophages (BMDM). Mouse bone marrow was obtained flushing femurs and tibiae with BMDM growth medium (Dulbecco's modified Eagle's medium containing 10% fetal calf serum [FCS], 20% L929-conditioned medium as source of colony-stimulating factor 1 (CSF-1), 1% sodium pyruvate, and 0.1% gentamicin). Cells were passed through a 70 m cell strainer, the concentration was adjusted to 2 ϫ 10 6 cells/ml in BMDM growth medium, and 20 ml was plated in 75-cm 2 tissue culture flasks for culturing in a humidified, 37°C, 5% CO 2 incubator for 1 week. Cells were washed with DMEM on alternate days to remove nonadherent cells, and fresh BMDM growth medium was added. Cells near confluence were removed by scraping, and 2 ϫ 10 6 cells were plated into 60-mm by 15-mm petri dishes and incubated for 2 days prior to virus infection. Cells were infected at a multiplicity of infection (MOI) of 1 with MHV-A59 for 1 h at 37°C, unattached virus was removed by washing, and 3 ml DMEM was added prior to incubation in a humidified, 37°C, 5% CO 2 incubator. At various times postinfection (p.i.), cells were lysed directly in 800 l TRIzol (Invitrogen) and stored at Ϫ70°C for RNA isolation as described above. BMDM were confirmed to be Ͼ90% F480 ϩ and CD11b ϩ cells by FACS analysis.
Nuclear protein fractionation and Western blotting. BMDM (1.2 ϫ ). Whole-cell extracts (6 ϫ 10 6 cells lysed in 40 l lysis buffer) and nuclear protein extracts were separated by 4-to-20% gradient SDS-PAGE (Bio-Rad) and transferred to Hybond PVDF membrane (GE Amersham). Membranes were labeled overnight with anti-IRF3 Ab (Santa Cruz sc-9082) and anti-phospho-S396 IRF3 Ab (human S396 ϭ murine S388; Cell Signaling no. 4947). Anti-HDAC1 Ab (Santa Cruz no. sc-7872), anti-actin Ab (Sigma no. A2066), and antialpha-tubulin Ab (Sigma no. T6074) were used as loading controls and the control for the absence of cytoplasmic proteins in nuclear fractions, respectively.
Cytokine and chemokine ELISA. Detection of IL-1␤ and IL-6 in virus infected brain supernatants were performed using mouse IL-1␤ enzymelinked immunosorbent assay (ELISA) Ready-Set-Go (eBioscience 88-7013) and IL-6 ELISA Ready-Set-Go (eBioscience 88-7064) according to the manufacturer's instructions. CCL5 in the brain supernatants was measured using mouse CCL5 ELISA kit (MMR00; R&D Systems, Minneapolis, MN) according to the manufacturer's instructions. IFN-␥ in brain supernatants was measured by ELISA as described previously (40) . Briefly, 96-well plates were coated overnight at 4°C with 100 l of 0.1 M disodium hydrogen phosphate, pH 9.5, containing 1 g/ml concentration of purified rat anti-mouse IFN-␥ MAb (R4-6A2; BD Bioscience). Nonspecific binding was blocked with 10% FCS in PBS for 1 h, followed by incubation with IFN-␥ recombinant cytokine standard (BD Biosciences) and samples at 4°C overnight. Bound IFN-␥ was detected using biotinylated rat antimouse IFN-␥ MAb (XMG1.2; BD Biosciences) and avidin peroxidase followed by 3,3=,5,5=-tetramethylbenzidine (TMB reagent set; BD Biosciences) 30 min later. Optical densities were read at 450 nm with a Bio-Rad model 680 microplate reader and analyzed using Microplate Manager 5.2 software (Bio-Rad Laboratories, Hercules, CA).
IFN-␣/␤ bioassay and serum alanine aminotransferase (ALT) assay. IFN-␣/␤ bioactivity in infected brain homogenates and BMDM supernatants was measured using LL171 cells (kindly provided by Volker Thiel), which are L929 cells stably transfected with an IFN-stimulated response element-luciferase reporter plasmid (ISRE-Luc) (41) . Infectious (9, 20, 42) , Ifit1 and Ifit2 are strongly upregulated by neurotropic MHV in an IFN-␣/␤ dependent manner (27, 28) . During CNS infections established by VSV and WNV, which both predominantly replicate in neurons, Ifit2 plays a vital protective role, whereas Ifit1 does not appear to contribute to antiviral immunity in adult mice (20, 21) . To determine if Ifit2 had a similarly potent protective effect against a neurotropic coronavirus family member with prominent neuron and glia tropism (35) , adult Ifit2 Ϫ/Ϫ mice were intracranially infected with MHV-A59. The majority of infected wt mice displayed only mild signs of encephalitis with ruffled fur (score of 1); only 10 to 20% of mice exhibited slightly hunched backs (score of 2) starting at day 6 postinfection (p.i.) ( Fig. 1 ). Clinical disease peaked at days 8 to 9 p.i., subsided by day 12 p.i. and was associated with a 100% survival rate. In contrast, disease onset was earlier and morbidity more severe in infected Ifit2 Ϫ/Ϫ mice. Clinical disease was evident as early as day 4 p.i. and encephalitis symptoms rapidly progressed in 50% to 60% of Ifit2 Ϫ/Ϫ mice as evidenced by severely hunched posture and wasting (score of 3), resulting in mortality between days 6 and 8 p.i. Infected Ifit2 Ϫ/Ϫ mice, which reached a clinical score of only 2 (slightly hunched posture) by day 5 p.i., all recovered by day 14 p.i. Very few infected Ifit2 Ϫ/Ϫ mice showed hind limb paralysis (Ͻ10%). Overall, all Ifit2 Ϫ/Ϫ mice that exhibited clinical scores of Ͼ2 succumbed to infection, while those with clinical scores of Ͻ2 at day 5 p.i. survived, despite higher disease severity than the wt controls during the recovery phase. By comparison, Ifnar Ϫ/Ϫ mice infected with the same virus dose all succumbed to infection by day 2 p.i. (Fig. 1) , indicating that other ISGs contribute to early protection in MHV-A59 infection. While a 5-fold increase in virus dose did not alter the survival of wt or the disease phenotype in Ifit2 Ϫ/Ϫ mice, a 50-fold increase resulted in 90% mortality in Ifit2 Ϫ/Ϫ mice without affecting survival in wt mice (data not shown). These results demonstrate a crucial role of Ifit2 in protection against neurotropic MHV-A59 infection.
RESULTS

Ifit2 protects against neurotropic MHV pathogenesis. Similar to other viral CNS infections
Ifit2 suppresses virus replication in the CNS and liver. To elucidate whether disease severity in Ifit2 Ϫ/Ϫ mice correlated with uncontrolled viral replication and spread, MHV-A59 replication was measured in the CNS and peripheral tissues (Fig. 2) . Infectious virus in brains of wt mice was maximal at days 3 and 5 p.i. but was reduced by ϳ2 logs by day 7 p.i. (3,930 Ϯ 890 PFU/brain). Ifit2 deficiency had no impact on initial virus replication at day 3 p.i., but significantly increased infectious virus by day 5 p.i. ( Fig.  2A ). Closer examination of Ifit2 Ϫ/Ϫ mice harboring 2-log-higher levels of virus in the brain revealed they all displayed more severe encephalitis as indicated by clinical scores of Ͼ2. Surviving Ifit2 Ϫ/Ϫ mice at day 7 p.i. harbored similar virus titers in the brain as wt ALT mice (5,330 Ϯ 1,450 PFU/brain). Analysis of viral nucleocapsid (N) transcripts in the brains confirmed overall higher replication in Ifit2 Ϫ/Ϫ mice and supported the correlation between increased virus replication and disease severity ( Fig. 2A ). The pattern of virus replication in spinal cords of infected Ifit2 Ϫ/Ϫ mice mirrored those in the brain at both days 3 and 5 p.i., with significantly higher replication noted at day 5 p.i. relative to wt mice ( Fig. 2A) .
IFN-␣/␤ mediates protection from uncontrolled MHV-A59 replication in liver, spleen, lungs, and CNS following peripheral infection (26) . The dual tropism of MHV-A59 for CNS as well as liver following intracranial infection may thus result in viral spread to peripheral organs, thereby contributing to mortality of Ifit2 Ϫ/Ϫ mice. However, after intracerebral infection of adult wt mice, viral mRNA levels in liver and spleen were 20-to 100-fold lower than brains, indicating minimal peripheral replication ( Fig.  2A) . Ifit2 deficiency was associated with a modest 2-to 4-fold increase in viral RNA in livers at day 3 p.i. (data not shown), and an ϳ15-fold increase at day 5 p.i. compared to wt mice ( Fig. 2A) , supporting an antiviral effect of Ifit2 in the liver. Moreover, elevated levels of viral RNA in livers in individual Ifit2 Ϫ/Ϫ mice correlated with elevated levels in the CNS and increased disease severity. Nevertheless, average viral mRNA levels in the livers of Ifit2 Ϫ/Ϫ mice were still ϳ16-fold lower than in the brain, and there was no gross evidence for hepatitis in either wt or Ifit2 Ϫ/Ϫ infected mice (data not shown). Furthermore, while serum ALT levels in Ifit2 Ϫ/Ϫ mice were slightly higher (41 IU/liter) compared to wt mice (16 IU/liter) at the peak of disease, both were within normal mouse serum ALT ranges (17 to 77 IU/liter), supporting limited liver damage in Ifit2 Ϫ/Ϫ mice. There was no evidence for elevated virus replication in spleens of Ifit2 Ϫ/Ϫ mice ( Fig. 2A) . Peripheral intraperitoneal infection also revealed significantly elevated virus replication in the liver of Ifit2 Ϫ/Ϫ compared to wt mice at day 5 p.i. (Fig. 2B ). However, virus was reduced by day 7 in both groups, consistent with the absence of clinical symptoms. These data support the notion that Ifit2 provides protection from MHV in both the CNS and liver. Significantly less virus replication in the liver than the brain in wt mice contrasts with results following intracranial infection of young adult 4-week-old mice (6) . Differences may reside in various MHV-A59 isolates, inherently increased replication capacity of neuronotropic viruses in the CNS of juvenile mice (43) (44) (45) (46) and/or enhanced dissemination from the CNS to visceral organs in young adult mice. Irrespectively, vastly increased morbidity and mortality of Ifit2 Ϫ/Ϫ mice following intracranial infection correlated with increased viral replication within the CNS and to a lesser extent with increased peripheral replication.
Ifit2 limits viral spread within the CNS. MHV-A59 infects neurons, and different glial cells in various brain regions, including olfactory bulbs, cortexes, midbrain regions, and brain stems in 4-week-old wt mice (47) (48) (49) . To determine if Ifit2 preferentially protects a specific brain region or cell type from infection in adult mice, brains were analyzed for distribution of viral antigen at day 5 p.i. The predominant cell type infected in wt mice had the morphology of microglia/macrophages (Fig. 3A) , although infected neurons were also easily identified, especially in the brain stem ( Fig. 3C and inset) . In Ifit2 Ϫ/Ϫ mice with severe clinical disease, viral antigen was vastly increased throughout the brain (Fig. 3B) , including the cerebellum, which showed minimal infection in wt mice ( Fig. 3E and F) . While microglia appeared to be the most frequently infected cell type in both wt and Ifit2 Ϫ/Ϫ mice, there was a proportionately higher number of infected neurons in the cerebrum (Fig. 3B and inset) and brain stem ( Fig. 3D and inset) of Ifit2 Ϫ/Ϫ mice. In the cerebellums of Ifit2 Ϫ/Ϫ mice, numerous neurons were infected in the molecular and granular cell layers, with some of the infected neurons forming small foci ( Fig. 3F and inset). The increased number of virus infected cells throughout the brain in Ifit2 Ϫ/Ϫ mice correlated with higher virus load compared to wt counterparts.
Cell type-specific markers were used to more precisely determine potential preferences in cellular tropism. In both wt and Ifit2 Ϫ/Ϫ mice, virus was readily detected in neurons (NeuN ϩ ) and microglia/macrophages (Iba1 ϩ ) but not in astrocytes (GFAP ϩ ) ( Fig. 4A to C) . The absence of infected astrocytes in the present study contrasts with MHV-A59 infection of 4-week-old mice (6) . This discrepancy may be due to different MHV-A59 isolates or host age-related differences, as indicated above (43) (44) (45) (46) . Additional analysis of viral RNA in oligodendroglia, microglia, and macrophages purified by FACS indicated that the relative increase in viral mRNA in Ifit2 Ϫ/Ϫ over wt cells was similar in all populations, ranging from 1.6-to 2.5-fold higher levels (Fig. 4D) . These results suggest that Ifit2 is protective against MHV-A59 infection in various CNS cell types in vivo, and its effects are most evident in the cerebellum and brainstem. Moreover, the focal small groups of neurons infected in the cerebellum (Fig. 3F and inset) suggest the possibility of enhanced neuron-to-neuron transmission in the absence of Ifit2.
Ifit2 deficiency results in impaired IFN-␣/␤ and ISG induction in the CNS. IFIT proteins can interfere directly with viral replication by disrupting translation or indirectly by interfering with RIG-I/MDA5 signaling altering downstream IFN-␣/␤ production (12, 13, 17, 18) . Although the latter has been observed only with human IFIT family members (17, 18) , Ifit2-mediated amplification of IFN-␣/␤ was recently observed in a murine endotoxin shock model (19) . Coronaviruses, including MHV-A59, induce IFN-␣/␤ in microglia/macrophages via MDA5 (50) . Furthermore, IFN-␣/␤ signaling on macrophages and dendritic cells is critical for the early containment of MHV within secondary lymphoid organs (51) . To ensure that uncontrolled virus replication was not due to impaired IFN-␣/␤ production, expression of Ifn-␣/␤ mRNA in the brains of Ifit2 Ϫ/Ϫ mice was compared to that in wt mice. Surprisingly, Ifn-␣4 and Ifn-␤1 mRNA expression was significantly reduced in Ifit2 Ϫ/Ϫ relative to wt mice at both days 3 and 5 p.i. (Fig. 5) . Moreover, at day 5 p.i., the decrease in Ifn-␣/␤ mRNA was most pronounced in Ifit2 Ϫ/Ϫ mice with clinical scores of Ͼ2 and high viral loads (ϳ10-fold) compared to wt controls ( Fig. 5 ). IFN levels in brain homogenates measured by IFN-␣/␤ bioassay were also significantly reduced in Ifit2 Ϫ/Ϫ mice compared to wt controls at day 5 p.i., although differences were not significant at day 3 (Fig. 5 ). Impaired IFN-␣/␤ was supported by significantly reduced expression of mRNA encoding the downstream ISGs Ifit1, Isg15, and Pkr compared to wt controls (Fig. 5 ). Reduced expression of IFN-␣/␤ and ISG mRNAs was also observed in spinal cords of infected Ifit2 Ϫ/Ϫ mice harboring high virus loads relative to wt mice (data not shown). These results suggest that the absence of Ifit2 impairs IFN-␣/␤ expression at the preclinical stage, when viral replication was still similar in both groups. Limited IFN-␣/␤ subsequently reduces ISG induction and contributes to increased virus replication, which in turn further impairs IFN-␣/␤ expression at later times p.i. These data support a novel Ifit2mediated positive feedback loop in propagating IFN-␣/␤ induction during MHV CNS infection.
Increased viral replication is generally associated with enhanced expression of proinflammatory cytokines and chemokines, which are partially regulated by activation of pattern recognition receptors. As MHV-A59 induces IFN-␣/␤ via MDA5 signaling (50), we assessed whether Ifit2 deficiency specifically affected the IFN-␣/␤ pathway or also modulated induction of pro-inflammatory cytokines and chemokines. Ifit2 deficiency did not alter mRNA expression of the acute-phase proinflammatory cytokines IL-6, NOS2, and TNF and only modestly reduced IL-1␤ mRNA at day 5 p.i. (Fig. 6 ). In addition, expression of mRNA encoding the macrophage or lymphocyte chemoattractants CCL2, CCL5, CXCL9, and CXCL10 were similar in infected Ifit2 Ϫ/Ϫ mice relative to wt mice (Fig. 6) . In contrast, mRNA expression of IFN-␥, a cytokine prominently released by T cells and critical for controlling virus in oligodendroglia (52) , was increased in Ifit2 Ϫ/Ϫ mice, consistent with enhanced T cell stimulation by increased virus load (Fig. 6 ). As Ifit2 may inhibit protein translation (10), expression of proinflammatory cytokines and chemokines was measured by ELISA. Ifit2 Ϫ/Ϫ mice bearing higher virus loads exhibited similar levels of IL-1␤ and IL-6 and slightly reduced CCL5 levels but increased IFN-␥ levels compared to wt mice (Fig. 7) . These protein patterns reflected mRNA levels and suggested no major role for Ifit2 in global translational inhibition in vivo. Characterization of cells recruited to the CNS by flow cytometry also revealed similar total numbers of infiltrating cells and no alterations in their composition (data not shown). Neutrophils comprised the most prominent population at day 3 p.i., and macrophages peaked at day 5 p.i. in both groups. Slightly higher numbers of infiltrating CD8 T cells in Ifit2 Ϫ/Ϫ brains with severe disease at day 5 p.i. coincided with increased IFN-␥ and supported intact adaptive immune responses in these mice (data not shown).
Overall, these results demonstrate that Ifit2 deficiency specifically impairs induction of IFN-␣/␤ but not proinflammatory cytokines or chemokines.
Kinetics and cell type-specific Ifit2 expression. Predominant induction of IFN-␣/␤ in microglia/macrophages following MHV-A59 CNS infection (50) implicated a specific role for Ifit2 in myeloid cells. We therefore assessed the kinetics of Ifit2 gene mRNA expression in relation to IFN-␣/␤ and characterized the prominent cell types inducing Ifit2 protein. Consistent with maximal expression of IFN-␣/␤ mRNA at day 3 p.i., Ifit2 transcripts were strongly induced by this time (Fig. 8A) . Moreover, although IFN- ␣/␤ mRNA gradually declined to basal levels by day 7 p.i., Ifit2 mRNA levels were sustained until day 5 p.i. and only gradually declined. At day 10 p.i., Ifit2 mRNA levels were still significantly higher than naive levels (Fig. 8A) .
The relative kinetics and expression of Ifit2 mRNA were also quantitated in FACS-purified microglia (CD45 lo F4/80 ϩ ), oligodendroglia (O4 ϩ ), and CNS-infiltrating monocytes/macrophages (CD45 hi F4/80 ϩ ). Ifit2 mRNA was expressed in all three cell types at day 3 p.i., reached maximal levels at day 5 p.i., and declined by day 7 p.i. (Fig. 8B ). Infiltrating macrophages expressed Ifit2 mRNA at increased levels compared to resident microglia and oligodendroglia. Peak Ifit2 mRNA expression correlated kinetically with the prominent effect of Ifit2 deficiency on virus replication at day 5 p.i.
To analyze the anatomical localization of Ifit2 protein (p54) in relation to virus distribution, brain sections from wt mice were costained for Ifit2 and viral protein. Ifit2 was detected in ependymal cells, the choroid plexus, and the brain parenchyma proximal to ventricles, as well as in focal areas within olfactory bulbs, the cortex, and midbrain regions (data not shown). Moreover, in all these regions, Ifit2 was found within and adjacent to infected cells, suggesting IFN-␣/␤-mediated induction in both infected and proximal uninfected cells (Fig. 8C) . The predominant cells expressing Ifit2 were neurons and microglia/macrophages, the major cell types infected during acute disease (Fig. 8C) . In contrast, Ifit2 was not detected in astrocytes (GFAP ϩ ) (Fig. 8C) , although astrocytes are capable of responding to IFN-␣/␤ and IFN-␥ (53) (54) (55) . The identity of Ifit2-expressing cells not costaining for CD11b, GFAP, or NeuN markers remains unknown. However, both nonactivated and modestly activated microglia expressing low levels of CD11b and oligodendrocytes are likely candidates. Overall, these data confirmed prominent Ifit2 expression in cell types known to induce IFN-␣/␤. Ifit2 deficiency impairs IFN-␣/␤ and ISG expression in microglia and macrophages. CNS resident microglia and infiltrating macrophages are the major source of MDA5-dependent IFN-␣/␤ induction following MHV infection, whereas neurons, oligodendroglia, and astrocytes do not produce IFN-␣/␤ (36, 50) . Impaired Ifn-␣/␤ mRNA expression in the CNS of infected Ifit2 Ϫ/Ϫ mice was thus most likely attributed to impaired IFN-␣/␤ expression in microglia or macrophages. This was verified by RNA analysis of microglia and CNS-infiltrating monocytes/macrophages purified from infected brains at days 4 and 5 p.i., correlating with onset of clinical signs and impaired IFN-␣/␤ expression in Ifit2 Ϫ/Ϫ mice. At day 4 p.i., mice were selected unbiasedly for cell preparations, as wt mice exhibited no clinical disease and Ifit2 Ϫ/Ϫ mice exhibited only very mild symptoms. However, as 50 to 60% of Ifit2 Ϫ/Ϫ mice progressed to severe disease by day 5 p.i., Ifit2 Ϫ/Ϫ mice were segregated into moderately and severely diseased groups to determine if expression patterns in monocytes/ macrophages and microglia reflected clinical disease. Both microglia and macrophages from Ifit2 Ϫ/Ϫ mice expressed higher levels of viral mRNA at day 4 p.i. but reduced levels of Ifn␤1, Ifn␣4, and Ifn␣5 mRNA relative to wt counterparts ( Fig. 9 ). Although Ifn␤1 mRNA levels were only marginally reduced in Ifit2 Ϫ/Ϫ microglia, Ifn␣4 and Ifn␣5 mRNA levels were reduced 5-fold and 3-fold, respectively. Monocyte/macrophages from Ifit2 Ϫ/Ϫ mice at day 4 p.i. revealed slight differences in the extent of the relative Ifn-␣/␤ mRNA decrease. Increasingly impaired Ifn-␣/␤ mRNA expression with increased viral load became even more evident by day 5 p.i. (Fig. 9 ). Ifn-␣/␤ mRNA levels were reduced more severely in Ifit2 Ϫ/Ϫ microglia and macrophages harboring high viral mRNA compared to both wt and Ifit2 Ϫ/Ϫ counterparts from mice with mild encephalitis (Fig. 9 ). Decreased Ifn-␣/␤ mRNA levels at day 5 p.i. compared to day 4 p.i. support the concept that an early reduction in IFN-␣/␤ leads to increased virus replication. Similarly, mRNA expression of the ISG Ifit1, Isg15, and Pkr was reduced 1.5to 2.5-fold in both microglia and macrophages (data not shown). In contrast, mRNA expression of the monocyte chemoattractant CCL2 (56) was not altered in Ifit2 Ϫ/Ϫ microglia or macrophages by day 4 p.i. (Fig. 9 ) and even increased in microglia from Ifit2 Ϫ/Ϫ mice with severe encephalitis compared to wt counterparts. Nevertheless, Ccl2 mRNA levels declined severely in macrophages. Reduced IFN-␣/␤ expression within the CNS in the absence of Ifit2 is thus attributed to both microglia and CNS-infiltrating macrophages.
As the infection rate of microglia/macrophages in vivo is low, based on histological analysis, BMDM were utilized to assess the effect of Ifit2 on virus replication and IFN-␣/␤ expression following MHV-A59 infection in vitro. Kinetic analysis of infected wt BMDM revealed that viral mRNA peaked at 12 and was maintained until 18 h p.i., whereas Ifn-␣/␤ mRNA expression peaked at 18 h p.i. Expression of Ifn-␣/␤ and ISG mRNAs was thus compared at 12 and 18 h p.i. Viral mRNA levels in Ifit2 Ϫ/Ϫ BMDM were not significantly different from those in wt BMDM, suggesting no direct effects of Ifit2 on virus replication (Fig. 10 ). However, Ifn-␤1 mRNA levels in infected Ifit2 Ϫ/Ϫ BMDM were reduced ϳ90-fold and ϳ60-fold at 12 and 18 h p.i., respectively (Fig.  10) . Expression of Ifn-␣4 and Ifn-␣5 mRNA was reduced even more robustly than that of Ifn-␤1 mRNA in Ifit2 Ϫ/Ϫ relative to wt BMDM at 18 compared to 12 h p.i., reflecting Ifn-␣4 and Ifn-␣5 amplification in wt but not Ifit2 Ϫ/Ϫ cells. Furthermore, IFN-␣/␤ in Ifit2 Ϫ/Ϫ BMDM supernatants was barely detectable (Ͻ3 U/ml) compared to wt macrophage supernatants (18 to 20 U/ml) at 12 h p.i. (Fig. 10) , reflecting impaired Ifn-␣/␤ transcript expression. The downstream ISG Ifit and Isg15 mRNAs were also reduced 10to 20-fold in the Ifit2 Ϫ/Ϫ compared to wt BMDM, albeit to a lesser extent than the IFN-␣/␤ genes. In contrast, mRNA expression of the proinflammatory cytokine TNF and chemokine CCL2 was only modestly reduced in Ifit2 Ϫ/Ϫ BMDM (Fig. 10 ). This confirmed the preferential impairment in IFN-␣/␤ induction compared to NF-B dependent genes observed in the infected brain. Impaired Ifn-␣/␤ and ISG mRNA expression in Ifit2 Ϫ/Ϫ BMDM, with no difference in viral replication, supports a direct role of Ifit2 in promoting the IFN-␣/␤ pathway rather than interfering with viral replication at the translational level.
Ifit2 deficiency impairs virus-induced IRF3 phosphorylation in BMDM. Both human IFIT3 and murine Ifit2 have been shown to enhance IFN-␣/␤ induction and amplification by upregulating IRF3 phosphorylation (18, 19) . IFIT3 exerts its function by bridging mitochondrial antiviral signaling protein (MAVS), the adapter for MDA5/RIG-I signaling, with the IRF3 kinase TBK1 (18) . As MDA5 is essential in inducing IFN-␣/␤ following MHV infection in macrophages/microglia, MHV-A59-infected wt and Ifit2 Ϫ/Ϫ BMDM were assessed for potential alterations in IRF3 modification. Immunoblotting of whole-cell lysates with anti-IRF3 Ab indicates that overall modification of IRF3 is independent of Ifit2 following 8 or 12 h p.i. Translocation of the modified IRF3 forms into the nucleus is also similar (Fig. 11 ). Nevertheless, use of a phospho-specific MAb to assess IRF3 phosphorylation at serine (S) residue 388, which marks the site most critical for transcriptional activity (57) , revealed a limited phosphorylation specifically at this site in both whole-cell lysates and nuclear extracts. These data support the idea that limited S388 phosphorylation of IRF3 in the absence of Ifit2 may contribute to reduced IFN-␣/␤ expression following MHV infection.
DISCUSSION
The contribution of individual ISGs to IFN-␣/␤-mediated innate immune control of coronavirus infections is not well understood. The classically studied OAS/RNase L pathway is antiviral in many RNA viral infections, including coxsackievirus, encephalomyocarditis virus (EMCV), and WNV (58-60), but does not exert prominent antiviral activity following MHV infection (28) . This was recently attributed to a virally encoded protein which actively degrades oligoadenylates, which are essential to activate RNase L (30) . Nevertheless, despite only modestly affecting MHV replication in microglia/macrophages in vivo, RNase L dampens and delays virus-induced demyelination (28) . The IFIT proteins are among the most strongly induced ISGs following MHV infection (27, 28) , similar to many other viral infections (9) . The present study revealed induction of Ifit2 in infected and proximal uninfected cells, supporting the idea that Ifit2 expression is confined to regional areas of virus replication within the CNS. Moreover, analysis of Ifit2 Ϫ/Ϫ mice identified Ifit2 as a major antiviral ISG limiting MHV replication in the CNS and liver and preventing both viral CNS dissemination and mortality.
Infection with a viral dose resulting in 100% mortality in Ifnar Ϫ/Ϫ mice within 2 days p.i. resulted in a delayed 60% mortality rate in Ifit2 Ϫ/Ϫ mice, while wt mice all survived. Mortality in Ifit2 Ϫ/Ϫ mice correlated with increased CNS virus replication as well as spread to the cerebellum and brainstem, which were minimally infected in wt mice. Although Ifit2 also displayed antiviral activity in the liver, reduced overall viral RNA levels in liver compared to brains of Ifit2 Ϫ/Ϫ mice and no gross evidence for hepatitis suggested a limited contribution of peripheral infection to morbidity and mortality. The absence of overt liver damage was further supported by lack of enhanced serum ALT levels in intracranially infected Ifit2 Ϫ/Ϫ compared to wt mice. Analysis of cellular tropism revealed no indication of preferential action of Ifit2 within distinct CNS cell types. Similar to wt mice, astrocytes were not infected in Ifit2 Ϫ/Ϫ mice. Microglia/macrophages constituted the most common cell type infected in both wt and Ifit2 Ϫ/Ϫ mice, including in the brain stem and cerebellum. The lack of astrocyte infection and minimal liver infection in wt mice contrasts with pathogenesis studies in younger (4-week-old) mice (6) , possibly due to use of distinct MHV-A59 isolates or host age-related differences (43) (44) (45) (46) . Irrespectively, the proportionately higher number of infected neurons in brain stem suggested that mortality of Ifit2 Ϫ/Ϫ mice may be due to cardiorespiratory failure. Furthermore, the spread of MHV to the cerebellum and brainstem may be attributed to similar mechanisms underlying Ifit2-mediated restriction of VSV neuronal spread following intranasal infection (20) . This notion is supported by the small foci of infected neurons in the cerebellum.
The mechanism by which Ifit2 exerts antiviral activity remains to be elucidated. A role of Ifit2 in supporting IFN-␣/␤ induction and amplification is indicated by reduced IFN-␣/␤ and ISG mRNA levels, as well as reduced IFN-␣/␤ activity, in the CNS of Ifit2 Ϫ/Ϫ mice even prior to symptomatic disease. Coronaviruses, including MHV-A59, are overall poor type I IFN inducers due to 2=-O-methylation of their capped mRNA (15) , which disguises viral RNAs and prevents recognition by MDA5 (15) . Nevertheless, macrophages and microglia infected with MHV do induce IFN-␣/␤ via MDA5 signaling (50) , and IFN-␣/␤ responsiveness by macrophages is critical to contain viral spread (51) . Reduced IFN-␣/␤ in the CNS of Ifit2 Ϫ/Ϫ mice was indeed directly attributed to myeloid cells, which are the prominent source of IFN-␣/␤ within the MHV-infected CNS (36, 50) . Together, the above data strongly imply that Ifit2 deficiency affects an MDA5-dependent pathway of IFN-␣/␤ induction (15, 17, 50) . MDA5 signaling recruits the downstream adaptor proteins TRAF3 or TRAF6 and the kinases TBK1 and IKK␣/␤ to the MAVS complex, thereby inducing IRF3/IRF7-mediated IFN-␣/␤ and NF-B-mediated cytokine expression (61) . Reduced IRF3 S388 phosphorylation in MHVinfected BMDM lysates in the absence of Ifit2 supported a correlation between Ifit2 and IRF3 activation, as suggested by the drastic reduction in both Ifn-␣/␤ mRNA and secreted protein in infected Ifit2 Ϫ/Ϫ compared to wt BMDM. Furthermore, both microglia and infiltrating monocytes purified from the infected CNS expressed reduced Ifn-␣/␤ mRNA levels despite elevated viral mRNA in the absence of Ifit2. As Ifit2 is itself an ISG, early IFN-␣/␤ induction would promote Ifit2-enhanced IRF3 transcriptional activation in a positive feedback loop. A role of Ifit2 in amplifying IFN-␣/␤ via enhanced IRF3 transcriptional activity is in agreement with a recent publication linking the absence of Ifit2 with reduced IRF3 phosphorylation and consequently reduced IFN-␣/␤ induction in a TLR4 stimulated sepsis model (19) . This notion is also supported by IFIT3-mediated potentiation of IFN-␣/␤ induction following VSV, Sendai virus, and influenza A virus infection by bridging TBK1 and the upstream adapter MAVS molecules in the RIG-I/MDA5 pathway (17, 18) . A subtle yet critical signaling threshold set early by the level of IRF3 activation in MHV-A59 Ifit2 Ϫ/Ϫ mice may thus contribute to the diverging CNS viral control and pathogenesis.
Reduced IRF3 phosphorylation in the absence of Ifit2 may further be exacerbated by MHV-derived decoy proteins competing for TBK1, as shown for the paramyxovirus V protein (62) . In this context, it is interesting that the MHV nucleocapsid protein is phosphorylated at several S residues, although the cellular kinases have not been identified (63, 64) . The MHV-A59 papain-like protease domain 2 of the nonstructural protein 3 may also contribute to inhibiting IRF3 activation and nuclear translocation (65) .
In contrast to impaired Ifn-␣/␤ mRNA, Ifit2 deficiency did not alter mRNA expression of either proinflammatory cytokines or chemokines, consistent with similar cellular CNS inflammation. Furthermore, neither ex vivo-purified microglia, infiltrating monocytes, nor BMDM cultures showed significantly reduced cytokine or chemokine mRNA or protein expression patterns. These results suggested that Ifit2 specifically regulates the IFN-␣/␤ induction pathway. These results are in contrast to reduced levels of IL-6 and TNF in the absence of Ifit2 in an LPS-induced septic shock model, despite similarly negative effects on IFN-␣/␤ expression (19) . The diverging results may be attributable to the distinct signaling molecules, as well as differences in strength of activation in the TLR4 versus MDA5 pathways, and thus highlight the plasticity of Ifit2 interactions.
Although regulation of IFN-␣/␤ expression during viral infections has been reported for human IFITs, this study is the first report to support a protective function of murine Ifit2 in promoting IFN-␣/␤ induction in vitro and in vivo using the neurotropic coronavirus encephalitis model. While Ifit2-enhanced IRF3 phosphorylation contributes to enhanced IFN-␣/␤ induction, the precise mechanisms by which Ifit2 interacts with components of the MDA5 pathway remain to be elucidated, but they are likely to be MHV specific. This is indicated by the absence of effects of Ifit2 deficiency on the pathogenesis of EMCV (20) , although this virus also induces IFN-␣/␤ via MDA5 (66) and does not have 2=-Omethylated 5=-capped mRNAs (15) . Minimal effects on proinflammatory cytokine and chemokine mRNA levels, consistent with similar CNS inflammatory infiltrates, further supports a specific interference of Ifit2 in the IFN-␣/␤ induction pathway. The novel role of murine Ifit2 in promoting type I IFN responses is thus reminiscent of IFN-␣/␤ modulation by human IFIT3.
